Amgen Whistle-Blower Loses Bid to Challenge Aranesp Deal
This article is for subscribers only.
A doctor who accused Amgen Inc. of illegally marketing drugs lost his bid for a court hearing to challenge the company’s $612 million civil settlement of misbranding claims.
U.S. District Judge Sterling Johnson denied the doctor’s request yesterday, according to a record filed in federal court in Brooklyn, New York. The order didn’t give any explanation for the decision.